Skip to main content
. Author manuscript; available in PMC: 2012 Feb 6.
Published in final edited form as: Cancer Chemother Pharmacol. 2010 Jul 2;67(4):919–926. doi: 10.1007/s00280-010-1394-x

Figure 2. Imatinib-induced changes in CD24 expression on the surface of MA-11 cells.

Figure 2

MA-11 cells were exposed to 25 μM Imatinib for 72 h, followed by incubation in drug-free medium for up to 48 h. After labeling of MA-11 cells with an anti-CD24-PE monoclonal antibody, cells were analyzed by flow cyotmetry for CD24 expression. P2 gates include only the CD24+ cells based on their respective isotype controls.